has been shown to reduce in vitro and in vivo liver cancer cell proliferation and invasion by inhibiting the autocrine vascular endothelial growth factor (VEGF)-induced PI3K/AKT signaling pathway [8]. This evidence concerns the gene VEGFA and liver cancer.